1.71
1.71 (0.55%)
As of Mar 06, 2024
Alterity Therapeutics Ltd [ATHE]
Source:
Company Overview
Alterity Therapeutics Limited was incorporated under the laws of the Commonwealth of Australia on November 11, 1997. Our mission is to develop therapeutic drugs designed to treat neurogenerative diseases, currently focusing on Parkinsonian and other movement disorders.
| Country | United States |
| Headquarters | melbourne |
| Phone Number | 61 3 9349 4906 |
| Industry | manufacturing |
| CEO | David A. Stamler |
| Website | www.alteritytherapeutics.com |